Source: Eur Respir J, 50 (4) 1700853; 10.1183/13993003.00853-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Viktoriya L. Kim, Ngaire A. Coombs, Karl J. Staples, Kristoffer K. Ostridge, Nicholas P. Williams, Stephen A. Wootton, Jeanne-Marie Devaster, Emmanuel Aris, Stuart C. Clarke, Andrew C. Tuck, Simon C. Bourne, Tom M.A. Wilkinson. Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohort. Eur Respir J, 50 (4) 1700853; 10.1183/13993003.00853-2017

Member's Comments

No comment yet.

Related content which might interest you: Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 The clinical characteristics of eosinophilic chronic obstructive pulmonary disease:A cohort study Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Lung core-predominant emphysema is associated with higher symptom burden in COPD: analysis of the COPDGene cohort Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Identification of factors associated with exacerbation risk in severe COPD: Multivariate analysis of the WISDOM study Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Eosinophilic inflammation in COPD: prevalence and clinical characteristics Source: Eur Respir J 2014; 44: 1697-1700 Year: 2014 Relationships between lung physiology and airway and systemic inflammation: a cohort study in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Longitudinal analysis of lung function decline with eosinophilic clustering in severe asthma Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases Year: 2011 Development of asthma in patients with eosinophilic bronchitis: prospective follow up study Source: Eur Respir J 2002; 20: Suppl. 38, 51s Year: 2002 The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016 The effect of smoking on exacerbation risk in eosinophilic patients with COPD Source: Eur Respir J, 50 (6) 1702086; 10.1183/13993003.02086-2017 Year: 2017 The effect of smoking on exacerbation risk in eosinophilic patients with COPD Source: Eur Respir J, 50 (6) 1701820; 10.1183/13993003.01820-2017 Year: 2017 Evolution of asthma in relation to the bronchial inflammatory phenotype: a follow-up study Source: International Congress 2018 – Asthma analysis Year: 2018 Development of chronic airway obstructive in patients with eosinophilic bronchitis: a prospective follow up study Source: Eur Respir J 2003; 22: Suppl. 45, 423s Year: 2003 Baseline data and responses to oral steroid intervention in asthma and COPD: interim report from the BIOAIR EU study Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007 Association of inflammatory biomarkers with comorbidity in chronic obstructive pulmonary disease – results from the COSYCONET cohort Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation Year: 2013 Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort Source: International Congress 2017 – COPD: latest insights into the management of patients Year: 2017 Identifying systemic inflammatory markers in the Melbourne COPD exacerbation cohort Source: Eur Respir J 2005; 26: Suppl. 49, 51s Year: 2005